DTx Pharma Appoints Michael Huang, MD as Chief Medical Officer
businesswire.com
news
2022-05-31 00:00:00

May 31, 2022 07:30 AM Eastern Daylight Time SAN DIEGO--(BUSINESS WIRE)--DTx Pharma, Inc. (DTx), a privately-held California biotechnology company developing novel RNA-based therapeutics to treat the genetic drivers of disease, today announced the appointment of Dr. Michael Huang as its Chief Medical Officer. Dr. Huang will provide leadership and supervision for DTx Pharma's pipeline of clinical development programs.



'We are excited to welcome Dr. Huang to DTx Pharma at this pivotal time in our evolution.
